2901 Hubbard Road, Suite 2723
Ann Arbor, MI 48109
Available to mentor
Kelvin L. Chou, M.D. is the Alexander S. and Gabriella Karp Professor of Neurology at the University of Michigan. He also serves as Co-Director of the Parkinson’s Disease and Movement Disorders Division and Associate Chair of Faculty Development in Neurology. Dr. Chou has been named to the Best Doctors of America list since 2011 and has clinical expertise and research interests in Parkinson’s disease (PD) and deep brain stimulation (DBS).
Dr. Chou serves as Co-Director of the STIM (Surgical Therapies Improving Movement) Program with a research focus on improving the ability to treat movement disorders patients through DBS. He is also an experienced clinical trialist, conducting numerous clinical trials on new therapies for PD, essential tremor and Huntington disease. He has published over 100 peer-reviewed journal articles, review articles or book chapters on PD and related movement disorders and serves on the editorial board for Neurology and Parkinsonism and Related Disorders.
A strong patient advocate, Dr. Chou serves on the Professional Advisory Board of the Michigan Parkinson Foundation and the Medical Advisory Board of the International Essential Tremor Foundation (IETF). He has also authored a book for patients and families called Deep Brain Stimulation: A New Life for People with Parkinson's, Dystonia and Essential Tremor.
-
MDUniversity of Michigan Medical School, M4101 MSI Box 0624 1301 Catherine, 1998
-
BSUniversity of Michigan, Ann Arbor, 1995
• Deep brain stimulation for Parkinson’s disease, Essential Tremor, and other movement disorders
• Experimental therapeutics for Parkinson’s disease, Essential Tremor and other movement disorders
• Non-motor and motor aspects of Parkinson’s disease
-
Liu X, Chou KL, Patil PG, Malaga KA. IEEE Trans Biomed Eng, 2024 Jan 26; PP:Journal ArticleEffect of anisotropic brain conductivity on patient-specific volume of tissue activation in deep brain stimulation for Parkinson disease.
DOI:10.1109/TBME.2024.3359119 PMID: 38277250 -
Spagna S, Ferng A, Chou K. Primary Care - Clinics in Office Practice, 2024 Jan 1;Journal ArticleEvaluation and Management of Tremor
DOI:10.1016/j.pop.2024.02.001 -
Fernandez HH, Macklin EA, Hauser RA, Chou KL, Cakmak YO, Ozsoy B, Fahn S, Parkinson Study Group EARSTIM-PD Investigators . Parkinsonism Relat Disord, 2023 Dec 27; 105959Journal ArticleIntrinsic auricular muscle zone stimulation for Parkinson disease: The EARSTIM-PD Phase II multi-center pilot study results.
DOI:10.1016/j.parkreldis.2023.105959 PMID: 38246833 -
Chou KL, Wyant KJ. 2024 Jan 1;Additional ScholarshipParkinson’s Masterclass: Advanced Therapeutics, eLearning CME modules (www.medmastery.com)
-
McGarry A, Rosanbalm S, Leinonen M, Olanow CW, To D, Bell A, Lee D, Chang J, Dubow J, Dhall R, Burdick D, Parashos S, Feuerstein J, Quinn J, Pahwa R, Afshari M, Ramirez-Zamora A, Chou K, Tarakad A, Luca C, Klos K, Bordelon Y, St Hiliare M-H, Shprecher D, Lee S, Dawson TM, Roschke V, Kieburtz K. Lancet Neurol, 2024 Jan; 23 (1): 37 - 45.Journal ArticleSafety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
DOI:10.1016/S1474-4422(23)00378-2 PMID: 38101901 -
Wyant KJ, Chou KL. 2023 Dec 1;Additional ScholarshipParkinson's Essentials, eLearning CME modules (www.medmastery.com)
-
Gasca-Salas C, Duff-Canning S, McArthur E, Armstrong MJ, Fox S, Meaney CA, Tang-Wai DF, Gill D, Eslinger PJ, Zadikoff C, Marshall FJ, Mapstone M, Chou KL, Persad C, Litvan I, Mast BT, Gerstenecker AT, Weintraub S, Marras C. Alzheimer Dis Assoc Disord, 2023 Oct; 37 (4): 335 - 342.Journal ArticlePredictors of Cognitive Change in Parkinson Disease: A 2-year Follow-up Study.
DOI:10.1097/WAD.0000000000000576 PMID: 37615480 -
Askari A, Lam JLW, Zhu BJ, Lu CW, Chou KL, Wyant KJ, Patil PG. Front Pain Res (Lausanne), 2023 4: 1240379Journal ArticleDorsal subthalamic deep brain stimulation improves pain in Parkinson's disease.
DOI:10.3389/fpain.2023.1240379 PMID: 37663307
